Conmed (CNMD) Net Income Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.00% |
| Dec 31, 2025 | -7.06% |
| Sep 30, 2025 | -16.03% |
| Jun 30, 2025 | 22.71% |
| Mar 31, 2025 | 0.37% |
| Dec 31, 2024 | 17.72% |
| Sep 30, 2024 | 47.69% |
| Jun 30, 2024 | 39.40% |
| Mar 31, 2024 | 80.77% |
| Dec 31, 2023 | 16.14% |
| Sep 30, 2023 | 22.14% |
| Jun 30, 2023 | 9.51% |
| Mar 31, 2023 | -29.78% |
| Dec 31, 2022 | -10.66% |
| Sep 30, 2022 | 45.01% |
| Jun 30, 2022 | -96.66% |
| Mar 31, 2022 | 39.56% |
| Dec 31, 2021 | 29.51% |
| Sep 30, 2021 | 15.30% |
| Jun 30, 2021 | 35.74% |
| Mar 31, 2021 | 44.74% |
| Dec 31, 2020 | 25.18% |
| Sep 30, 2020 | -5.04% |
| Jun 30, 2020 | -41.50% |
| Mar 31, 2020 | -1.25% |
| Dec 31, 2019 | 5.66% |
| Sep 30, 2019 | 28.73% |
| Jun 30, 2019 | -11.10% |
| Mar 31, 2019 | -34.74% |
| Dec 31, 2018 | 8.89% |
| Sep 30, 2018 | 0.48% |
| Jun 30, 2018 | -1.77% |
| Mar 31, 2018 | 0.31% |
| Dec 31, 2017 | 33.78% |
| Sep 30, 2017 | -5.04% |
| Jun 30, 2017 | -9.83% |
| Mar 31, 2017 | -19.69% |
| Dec 31, 2016 | 17.78% |
| Sep 30, 2016 | -2.23% |
| Jun 30, 2016 | -19.78% |
| Mar 31, 2016 | -17.63% |
| Dec 31, 2015 | 2.43% |
| Sep 30, 2015 | 0.26% |
| Jun 30, 2015 | 0.42% |